Carol Greider: The Christmas Day Discovery of Telomerase
Sunny Youn, Research Fellow at Product Manager Accelerator, shared a post on LinkedIn:
“Re-posting this article about some breakthroughs in science by unsung women heros…I mean, heroines
In the early 1980s, scientists Elizabeth Blackburn and Jack Szostak discovered that some cells could maintain their telomeres—protective DNA caps on chromosomes—without shortening, suggesting the existence of an unknown enzyme that rebuilt them. In 1984, 23-year old graduate student Carol Greider joined Blackburn’s lab at UC Berkeley to find that enzyme.
After nine months of failed experiments using Tetrahymena (a pond organism rich in telomeres), Greider ran one more test on Christmas Day, 1984, and finally saw proof: a faint DNA pattern showing telomere extension. She had discovered telomerase, the enzyme that maintains telomere length.
Following months of confirmation, Greider and Blackburn published their findings in 1985—initially overlooked because the work used “pond scum.” Later research proved telomerase existed in humans and was key to cell aging and cancer, as it enables cancer cells to divide indefinitely.
Greider earned her PhD, led her own lab, and continued groundbreaking telomere research. In 2009, she, Blackburn, and Szostak received the Nobel Prize in Physiology or Medicine for their discovery.
Her story illustrates how major breakthroughs often arise from curiosity, persistence, and patience—not grand plans. The discovery of telomerase transformed science across fields like aging, cancer biology, degenerative disease, and longevity research—all tracing back to one determined graduate student working alone on Christmas morning.”
Stay updated with Hemostasis Today.
-
Jun 1, 2026, 18:51Francesco Giurazza: New Publication on Glubran-2 in Acute Bleeding Patients with Coagulopathies
-
Jun 1, 2026, 18:50Donald Arnold is the Recipient of the Roberts Award – ISTH
-
Jun 1, 2026, 18:49Amirreza Jabbaripour Sarmadian: My First Paper as Corresponding Author on Upper Extremity DVT Following COVID-19 Vaccination
-
Jun 1, 2026, 18:49James P. Crowley: How Combining Vitamin D analogs with Chemotherapy Impacts Survival Outcomes
-
Jun 1, 2026, 18:42Debojyoti Chakraborty: Small But Meaningful Steps Toward A Gene Editing Trial For Sickle Cell Disease In India
-
Jun 1, 2026, 17:14Tiffany Gacel: What an Incredible Day With NBCA and The Red Bus Tour at Memorial at Gulfport?
-
Jun 1, 2026, 17:12Marie-Claire Kofi: Poster Highlights the Process of Establishing the Sickle Cell Transitions Policy Lab
-
Jun 1, 2026, 17:00Azusa Nagao: Organizing the Symposium on Women and Bleeding Disorders at JSTH Annual Meeting
-
Jun 1, 2026, 16:57Kuljeet Kaur: Approach to Anemia – More Than Just a Low Hemoglobin